Trial intelligence / Profile preview

Silybin Effects in Hypertensive Patients with High 1-h Glucose

NCT03538327Phase 4Completed

Sponsor
University of Magna Graecia
Start
Oct 2013
Primary completion
Apr 2014
Modality
Small Molecules
01

Overview

A Phase 4 trial of silibinin in hypertension (HTN), sponsored by University of Magna Graecia. Started Oct 2013; status: completed.

02

Drugs

silibinin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT03538327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03538327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call